{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:02:53Z","timestamp":1762113773631},"publisher-location":"Cham","reference-count":52,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319997155"},{"type":"electronic","value":"9783319997162"}],"license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-319-99716-2_7","type":"book-chapter","created":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T11:33:57Z","timestamp":1546169637000},"page":"145-161","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Adult T-Cell Leukemia-Lymphoma"],"prefix":"10.1007","author":[{"given":"Wataru","family":"Munakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127:2375\u20132390","journal-title":"Blood"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC et al (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058\u20136068","journal-title":"Oncogene"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1349-7006.2010.01820.x","volume":"102","author":"S Sonoda","year":"2011","unstructured":"Sonoda S, Li HC, Tajima K (2011) Ethnoepidemiology of HTLV-1 related diseases: ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal. Cancer Sci 102:295\u2013301","journal-title":"Cancer Sci"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.23181","volume":"84","author":"M Satake","year":"2012","unstructured":"Satake M, Yamaguchi K, Tadokoro K (2012) Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol 84:327\u2013335","journal-title":"J Med Virol"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3:388","journal-title":"Front Microbiol"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A et al (2010) Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 116:1211\u20131219","journal-title":"Blood"},{"issue":"Suppl 1","key":"7_CR7","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/00042560-199600001-00005","volume":"13","author":"B Hanchard","year":"1996","unstructured":"Hanchard B (1996) Adult T-cell leukemia\/lymphoma in Jamaica: 1986\u20131995. J Acquir Immune Defic Syndr Hum Retrovirol 13(Suppl 1):S20\u2013S25","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/ijc.2910600617","volume":"60","author":"MS Pombo de Oliveira","year":"1995","unstructured":"Pombo de Oliveira MS, Matutes E, Schulz T et al (1995) T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. Int J Cancer 60:823\u2013827","journal-title":"Int J Cancer"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-14-0572","volume":"20","author":"K Tsukasaki","year":"2014","unstructured":"Tsukasaki K, Tobinai K (2014) Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research. Clin Cancer Res 20:5217\u20135225","journal-title":"Clin Cancer Res"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J, Yoshida M et al (2006) HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 103:720\u2013725","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","volume":"21","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Nakano K, Miyake A et al (2012) Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 21:121\u2013135","journal-title":"Cancer Cell"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A et al (2015) Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet 47:1304\u20131315","journal-title":"Nat Genet"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature18294","volume":"534","author":"K Kataoka","year":"2016","unstructured":"Kataoka K, Shiraishi Y, Takeda Y et al (2016) Aberrant PD-L1 expression through 3\u2019-UTR disruption in multiple cancers. Nature 534:402\u2013406","journal-title":"Nature"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","volume":"127","author":"D Fujikawa","year":"2016","unstructured":"Fujikawa D, Nakagawa S, Hori M et al (2016) Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood 127:1790\u20131802","journal-title":"Blood"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984\u201387). Br J Haematol 79:428\u2013437","journal-title":"Br J Haematol"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D et al (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124\u20134130","journal-title":"J Clin Oncol"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.194.6.847","volume":"194","author":"A Iellem","year":"2001","unstructured":"Iellem A, Mariani M, Lang R et al (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194:847\u2013853","journal-title":"J Exp Med"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.4049\/jimmunol.161.10.5111","volume":"161","author":"D D\u2019Ambrosio","year":"1998","unstructured":"D\u2019Ambrosio D, Iellem A, Bonecchi R et al (1998) Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 161:5111\u20135115","journal-title":"J Immunol"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/eji.200324429","volume":"34","author":"M Mariani","year":"2004","unstructured":"Mariani M, Lang R, Binda E et al (2004) Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. Eur J Immunol 34:231\u2013240","journal-title":"Eur J Immunol"},{"key":"7_CR20","first-page":"3625","volume":"9","author":"T Ishida","year":"2003","unstructured":"Ishida T, Utsunomiya A, Iida S et al (2003) Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9:3625\u20133634","journal-title":"Clin Cancer Res"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.V96.2.685","volume":"96","author":"D Jones","year":"2000","unstructured":"Jones D, O\u2019Hara C, Kraus MD et al (2000) Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 96:685\u2013690","journal-title":"Blood"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-04-0371","volume":"10","author":"T Ishida","year":"2004","unstructured":"Ishida T, Inagaki H, Utsunomiya A et al (2004) CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res 10:5494\u20135500","journal-title":"Clin Cancer Res"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/01.pas.0000213267.92349.59","volume":"30","author":"H Yagi","year":"2006","unstructured":"Yagi H, Seo N, Ohshima A et al (2006) Chemokine receptor expression in cutaneous T cell and NK\/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol 30:1111\u20131119","journal-title":"Am J Surg Pathol"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1084\/jem.20140987","volume":"211","author":"M Nakagawa","year":"2014","unstructured":"Nakagawa M, Schmitz R, Xiao W et al (2014) Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma. J Exp Med 211:2497\u20132505","journal-title":"J Exp Med"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H et al (2001) A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical oncology group study 9303. Br J Haematol 113:375\u2013382","journal-title":"Br J Haematol"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H et al (2007) VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801. J Clin Oncol 25:5458\u20135464","journal-title":"J Clin Oncol"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A et al (2010) Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116:1369\u20131376","journal-title":"Blood"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bmt.2010.92","volume":"46","author":"I Choi","year":"2011","unstructured":"Choi I, Tanosaki R, Uike N et al (2011) Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials. Bone Marrow Transpl 46:116\u2013118","journal-title":"Bone Marrow Transpl"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","volume":"120","author":"T Ishida","year":"2012","unstructured":"Ishida T, Hishizawa M, Kato K et al (2012) Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 120:1734\u20131741","journal-title":"Blood"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","volume":"29","author":"A Hodson","year":"2011","unstructured":"Hodson A, Crichton S, Montoto S et al (2011) Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma. J Clin Oncol 29:4696\u20134701","journal-title":"J Clin Oncol"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W Jr, Kaplan MH et al (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 332:1744\u20131748","journal-title":"N Engl J Med"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, Bouscary D, Gessain A et al (1995) Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 332:1749\u20131751","journal-title":"N Engl J Med"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","volume":"108","author":"A Datta","year":"2006","unstructured":"Datta A, Bellon M, Sinha-Datta U et al (2006) Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 108:1021\u20131029","journal-title":"Blood"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-4690-10-52","volume":"10","author":"S Kinpara","year":"2013","unstructured":"Kinpara S, Kijiyama M, Takamori A et al (2013) Interferon-alpha (IFN-alpha) suppresses HTLV-1 gene expression and cell cycling, while IFN-alpha combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells. Retrovirology 10:52","journal-title":"Retrovirology"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","volume":"28","author":"A Bazarbachi","year":"2010","unstructured":"Bazarbachi A, Plumelle Y, Carlos Ramos J et al (2010) Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 28:4177\u20134183","journal-title":"J Clin Oncol"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","volume":"16","author":"T Ishii","year":"2010","unstructured":"Ishii T, Ishida T, Utsunomiya A et al (2010) Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res 16:1520\u20131531","journal-title":"Clin Cancer Res"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","volume":"278","author":"T Shinkawa","year":"2003","unstructured":"Shinkawa T, Nakamura K, Yamane N et al (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466\u20133473","journal-title":"J Biol Chem"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","volume":"64","author":"R Niwa","year":"2004","unstructured":"Niwa R, Shoji-Hosaka E, Sakurada M et al (2004) Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Res 64:2127\u20132133","journal-title":"Cancer Res"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1158\/1078-0432.CCR-04-2263","volume":"11","author":"R Niwa","year":"2005","unstructured":"Niwa R, Sakurada M, Kobayashi Y et al (2005) Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density. Clin Cancer Res 11:2327\u20132336","journal-title":"Clin Cancer Res"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K et al (2010) Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28:1591\u20131598","journal-title":"J Clin Oncol"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N et al (2012) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30:837\u2013842","journal-title":"J Clin Oncol"},{"key":"7_CR42","unstructured":"Phillips AA, Fields P, Hermine O et al (2016) A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator\u2019s choice in the treatment of patients with relapsed\/refractory adult T-cell leukemia-lymphoma. J Clin Oncol 34. abstrct 7501"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","volume":"169","author":"T Ishida","year":"2015","unstructured":"Ishida T, Jo T, Takemoto S et al (2015) Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672\u2013682","journal-title":"Br J Haematol"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/cas.12116","volume":"104","author":"T Ishida","year":"2013","unstructured":"Ishida T, Ito A, Sato F et al (2013) Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/lymphoma. Cancer Sci 104:647\u2013650","journal-title":"Cancer Sci"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","volume":"34","author":"S Fuji","year":"2016","unstructured":"Fuji S, Inoue Y, Utsunomiya A et al (2016) Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-Cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality. J Clin Oncol 34:3426\u20133433","journal-title":"J Clin Oncol"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S2352-3026(15)00284-7","volume":"3","author":"M Ogura","year":"2016","unstructured":"Ogura M, Imaizumi Y, Uike N et al (2016) Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study. Lancet Haematol 3:e107\u2013e118","journal-title":"Lancet Haematol"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","volume":"34","author":"T Ishida","year":"2016","unstructured":"Ishida T, Fujiwara H, Nosaka K et al (2016) Multicenter phase ii study of lenalidomide in relapsed or recurrent adult T-Cell leukemia\/lymphoma: ATLL-002. J Clin Oncol 34:4086\u20134093","journal-title":"J Clin Oncol"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2009","unstructured":"Tsukasaki K, Hermine O, Bazarbachi A et al (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27:453\u2013459","journal-title":"J Clin Oncol"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","volume":"115","author":"Y Takasaki","year":"2010","unstructured":"Takasaki Y, Iwanaga M, Imaizumi Y et al (2010) Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 115:4337\u20134343","journal-title":"Blood"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A et al (2015) Treatment and survival among 1594 patients with ATL. Blood 126:2570\u20132577","journal-title":"Blood"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","volume":"30","author":"H Katsuya","year":"2012","unstructured":"Katsuya H, Yamanaka T, Ishitsuka K et al (2012) Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma. J Clin Oncol 30:1635\u20131640","journal-title":"J Clin Oncol"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bjh.12962","volume":"166","author":"T Fukushima","year":"2014","unstructured":"Fukushima T, Nomura S, Shimoyama M et al (2014) Japan clinical oncology group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 166:739\u2013748","journal-title":"Br J Haematol"}],"container-title":["Cancer Treatment and Research","T-Cell and NK-Cell Lymphomas"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-99716-2_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T11:09:21Z","timestamp":1694516961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-99716-2_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"ISBN":["9783319997155","9783319997162"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-99716-2_7","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"type":"print","value":"0927-3042"},{"type":"electronic","value":"2509-8497"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}